clinical trials with 18F-PSMA-1007 @BaconLab

Last week, Bacon Lab in Argentina started its clinical trials with 18F-PSMA-1007 (approved locally by ANMAT) as part of the Global initiative from Heildeberg. The first  patients were injected with 18F-PSMA-1007 and the resulting in images were of high sensitivity and  accuracy in the detection of  multiple metastases in prostate cancer patients. The high accuracy of 18F-PSMA-1007 will help to better manage patients and open more possibilities for apropriate therapies, commented Dr. Bastianello from CEMIC University hospital.
The synthesis was performed on the IBA Synthera® module  with more 40% ndc yields and product fully compliant with the specifications.